Welcome to our dedicated page for CARECLOUD news (Ticker: CCLDO), a resource for investors and traders seeking the latest updates and insights on CARECLOUD stock.
CareCloud Inc (CCLDO) delivers cloud-based healthcare technology solutions that power high-growth medical practices through innovative EHR systems, practice management tools, and telehealth platforms. This dedicated news hub provides investors and industry professionals with timely updates on the company’s operational milestones, financial performance, and strategic initiatives.
Access authoritative reporting on CareCloud’s latest developments including quarterly earnings, product enhancements, leadership changes, and strategic partnerships. Our curated collection ensures you stay informed about critical updates affecting this healthcare IT innovator’s market position and service offerings.
Key focus areas include advancements in CareCloud’s revenue cycle management solutions, expansions of its telehealth capabilities, and developments in healthcare data analytics. All content is verified through primary sources to maintain accuracy and compliance with financial disclosure standards.
Bookmark this page for streamlined access to CareCloud’s official communications and third-party analyses. Regularly updated to reflect new developments in cloud-based healthcare technology and corporate strategy.
CareCloud (Nasdaq: CCLD), a healthcare technology and generative AI solutions provider, has announced monthly cash dividend payments for its Series A and Series B Preferred Stock for July, August, and September 2025.
The company will pay $0.18229 per share monthly dividend for both Series A and B Preferred Stock. Series A holders will receive an additional $0.04688 per share payment due to historical rate adjustments. Both series carry an 8.75% annual dividend rate on the $25.00 per share liquidation preference. Dividends will be paid on August 15, September 15, and October 15, 2025.
Series A holders converted before March 6, 2025, are not eligible for these payments as they have already received their dividends in shares.CareCloud (Nasdaq: CCLD) has launched an AI-driven, fully integrated dermatology Electronic Health Record (EHR) system targeting the $9 billion U.S. dermatology services market. The cloud-based platform combines AI-powered documentation, advanced image management, and seamless integration with practice management, revenue cycle management (RCM), and telehealth services.
The comprehensive solution features AI-powered charting, customizable templates, advanced image management, integrated telehealth capabilities, optimized billing, and seamless interoperability with labs and pharmacies. The platform aims to streamline clinical workflows, enhance patient engagement, and improve financial outcomes for dermatology practices of all sizes.
CareCloud (Nasdaq: CCLD), a provider of AI-powered healthcare technology and revenue cycle management solutions, has scheduled its Q2 2025 earnings release for August 5, 2025, before market opening.
The company will host a conference call for investors at 8:30 a.m. Eastern Time on the same day. Investors can access the live webcast and presentation slides at ir.carecloud.com/events, or join via audio-only option by dialing 201-389-0920.
CareCloud (Nasdaq: CCLD), a healthcare technology and revenue cycle management solutions provider, reported a remarkable 70% stock price increase in Q2 2025, emerging as one of the top gainers in the Russell Microcap® Index. The company was officially added to the index on June 30, 2025.
Key developments include the launch of an AI Center of Excellence, resumed M&A activities, conversion of 3.5 million Series A Preferred shares into Common Stock, and a healthy cash position of over $10 million. The company's strategic focus on AI innovation and intelligent health solutions positions it for continued growth in 2025.
CareCloud (Nasdaq: CCLD), an AI-driven healthcare technology solutions provider, has been added to the Russell Microcap® Index effective June 30, 2025. The company experienced significant growth with its stock price rising approximately 70% during Q2 2025.
Notable achievements include launching an AI Center of Excellence, resuming acquisition activities, and maintaining a strong cash position of $10 million at Q2 end. Additionally, approximately 3.5 million shares of Series A Preferred Stock were converted to Common Stock on March 6, 2025.
CareCloud (Nasdaq: CCLD), an AI-driven healthcare technology solutions provider, has announced reaching a significant milestone with a public float of $85.1 million as of June 30, 2025. This achievement triggers new SEC compliance requirements, specifically the need for auditor attestation of Internal Control over Financial Reporting (ICFR) under Sarbanes-Oxley Act Section 404(b).
The Company's current audit firm has indicated it lacks capacity to perform the required ICFR attestation. As SEC regulations mandate the same firm conduct both financial statement audit and ICFR attestation, CareCloud has initiated a search for a new audit firm to handle these responsibilities for fiscal year 2025.
CareCloud (Nasdaq: CCLD), an AI-driven healthcare technology solutions provider, announced that its current independent registered public accounting firm may resign if the company requires an Internal Control over Financial Reporting (ICFR) attestation for fiscal year 2025.
The requirement for ICFR attestation will be determined by CareCloud's public float as of June 30, 2025. If it reaches or exceeds $75 million, the company will be classified as an accelerated filer, necessitating the attestation under Section 404(b) of the Sarbanes-Oxley Act. The current audit firm has stated it lacks capacity for ICFR attestation, which would require CareCloud to engage a new accounting firm as SEC rules mandate the same firm conduct both financial statement audit and ICFR attestation.
CareCloud (NASDAQ: CCLD) held its 2025 Annual Shareholders' Meeting on May 27, 2025, where shareholders approved three key proposals. The meeting resulted in the re-election of three board members - Anne Busquet, Bill Korn, and Lawrence Sharnak - for two-year terms. Shareholders also approved the compensation package for named executive officers and the appointment of Rosenberg Rich Baker Berman, P.A. as the company's independent registered public accounting firm for the fiscal year 2025.
The re-elected board members bring significant experience: Busquet has over 30 years of executive experience with American Express and Interactive Corp, Korn previously served as CareCloud's CFO for 10 years until October 2023, and Sharnak held various senior leadership roles during his 30-year tenure at American Express.
CareCloud (NASDAQ: CCLD) has been named the "Top Healthcare IT Pick for 2025" by Maxim Group, highlighting the company's AI strategy and strong financial performance. Maxim Group's analyst Allen Klee emphasized CareCloud's attractive valuation, noting it trades at a 2026 EV/EBITDA multiple of 5.0x, significantly below the peer group average of 12.5x.
The company reported impressive Q1 2025 results with 52% year-over-year adjusted EBITDA growth. CareCloud's recently launched AI Center of Excellence, starting with 50 AI professionals and planning to expand to 500 by year-end, demonstrates its commitment to AI integration. The company's AI suite includes tools like cirrusAI Notes, cirrusAI Appeals, and cirrusAI Voice, positioning CareCloud as a leader in healthcare AI solutions.
FAQ
What is the current stock price of CARECLOUD (CCLDO)?
